MS NO.: PJMDS/CR/013/2024 

Case Report

Submitted: July 13, 2024

Revised: September 8, 2024

Accepted: September 10, 2024

Body Packing of Illicit Drugs: An Incidental Radiological Diagnosis in a COVID-Positive Patient

Ameet Kumar1, Muhammad Saqib Qamar Ishaqi2, Syed Muhammad Shahnawaz Hyder3, Aneeta4, Pooja5

Corresponding Author 

Ameet Kumar1

Email: [email protected]

Affiliations: 

The Indus Hospital, Karachi1,2,3

National Institute of Child Health (NICH), Karachi4

Liaquat University Hospital (LUH), Hyderabad5

Postgraduate Resident1

Consultant Radiologist2,3,4

Consultant Gastroenterologist5

 

ABSTRACT

Background: Body packing, which involves the internal concealment of illicit drugs to smuggle them across borders, remains one of the most critical diagnosis and management issues and remains difficult to understand, especially when discovered incidentally. Often such drugs' concealment during packing may radiate within the body and emit signals during necessary scans conducted for other evaluation conditions, radiological imaging plays a crucial role in these cases. This paper aims to present a peculiar case of body packing detected in a patient with COVID-19 who was simply undergoing routine scans, raising questions regarding the regular course of management for infectious and criminal matters. The case also raises critical issues of how imaging assists in solving critical cases within complex and overlapping clinical cases.

 

Case Presentation: A 31-year-old male, a chronic abuser of mawa, presented with complaints of fever, constipation, abdominal pain and altered level of consciousness. COVID-19 PCR was done and the patient was found positive for the virus. The patient was started on initial management with isolation. Further progression of the patient’s symptoms necessitated the imaging investigations during which hyperdense capsules were observed in the gastrointestinal tract congenial to the diagnosis of body packing. Toxicology results confirmed the presence of opiate. During endoscopy, a retrieval of two capsules was performed, but the patients’ clinical condition continued on deterioration, the patient developed quadriparesis and coma and deteriorated to death post intervention. CT findings showed that there were global drug-related complications rather than pneumonia related to COVID.

 

Conclusion: Body packing has grown worldwide. This case report highlights the importance of recognising body packing as a cause of abdominal pain and other gastrointestinal symptoms in drug users and travellers. CT scans help to diagnose these patients and their complications.

 

Keywords: Body packing, Body positive in COVID patient, Radiological imaging of body packing

 

INTRODUCTION

Body packers, initially described in 1973, are individuals involved with the illegal smuggling of illicit drugs via intracorporeal concealment. The drugs are generally concealed in bodypacks, which entail small oval-shaped packets containing tightly-wrapped capsules or condoms, ingested normally by mouth; pellets of swallowed cocaine can be found this way. These are called body packers (who swallow drug packets) and body pushers (insertion in a cavitary orifice)1.

Cocaine, heroin, methamphetamines and cannabis are the most common illicit drugs that are smuggled into many countries2.

Body packers are often asymptomatic; however, severe complications can quickly arise when the packets ruptures or leak into vessel (body-packer syndrome). This can precipitate serious, potentially life-threatening consequences such as seizure, respiratory depression and cardiac arrest if systemic drug absorption occurs3. Mechanical problems such as gastrointestinal obstruction and perforation are serious issues, particularly in the setting of packet ingestions4.

Clinical suspicion for body packing is difficult as symptoms are commonly nonspecific (eg, abdominal pain, constipation or altered mental status). Otherwise, these symptoms are often nonspecific and can be mistaken for other conditions.5 Imaging plays a significant role in body packing diagnosis. Only 40% to 90% of the time can medication packets be seen on radiographs, depending on the size and quantity of contrast material in the capsules.6 The most effective diagnostic tool is computed tomography (CT) without contrast because of its sensitivity to drug-filled packets and associated complications between 95.6%-100%7, but ultrasound can be a suitable option for low-resource settings as well5. CT scanning is also useful to instruct, number, size and location of packets but may not detect disintegration or ruption of drug containers8. In the realm of illegal narcotics, body packing has long been used as a smuggling technique since it's essentially a more covert and straightforward approach to get by customs. Body packers continue to be a problem, even with improvements in drug screening measures at the borders. When diagnosing and treating them, doctors must exercise caution to avoid a tragic consequence.

 

CASE REPORT

A 31-year-old male, chronic mawa (chewing tobacco) addict looking drowsy presented with fever -1 day and constipation - 4 days followed by diffuse abdominal pain in addition to altered sensorium. On chest examination had bilateral basal crepitations. A COVID PCR was sent because of the current pandemic, which testing positive for his diagnosis. The patient was first placed in an isolation unit when it was determined that his COVID-19 status was the cause of his symptoms. But rather of getting better, his problems grew worse over time. The nonspecific abdominal X-ray (erect and supine). A CT chest and abdominal scan with IV contrast demonstrated diffuse large hyperdense capsules packed in the stomach, duodenum and colon consistent with body packing. The biggest capsule was of 3.5 cm in length and showed an attenuation range between 150 to 400 Hounsfield units respectively (Fig. The stomach was scanned unenhanced in the axial plane (figure 1), and showed a hyperdense capsule with an attenuation of 250 HU. A second capsule was seen in the transverse colon on coronal CT scan (Figure 2). The average attenuation of the capsules in the proximal duodenum was lower, measuring 110 Hounsfield units that suggested disintegration (Figure 3). Findings in the chest on CT were not highly suspicious for COVID pneumonia and more likely systemic drug-related complications.

Urine toxicology was positive for opiates. Thus, upper GIT endoscopy was performed and two capsules were retrieved from the proximal bowel. Despite this despite treatment, the patient's clinical status worsened over time (he developed an entire depressive episode or drowsiness which later evolved to weakness and paresis of his four limbs leaving him with a Glasgow coma score 2T/10). Unfortunately, the patient could not be revived and died at the hospital.

 

 

 

DISCUSSION

Over the last two decades cases of drug smuggling are increased with young to middle aged males most commonly involved3. Cocaine is one of the most smuggled drugs followed by heroin, cannabinoid and methamphetamine. Most frequent locations are gastrointestinal tract, vagina and ears. Condoms, latex gloves and balloons are typically used as drug packets for keeping drugs in the body4. Even after sophisticated techniques of packaging, body packers are at increased risk of complications which can be divided into:

 

 

Systemic absorption can lead to drowsiness, epileptic seizures, neuropathies, rhabdomyolysis, renal failure and cardiac arrest. If not promptly diagnosed and managed complications can lead

to coma and death of patient. Radiological imaging play essential role in diagnosis. Plain radiography is still most widely used imaging modality to diagnose with sensitivity ranging from

40% to 90% depending on size, location, type of drug and foiling material. It can detect drug filled packets of 2-8 cm2,5. Due to high sensitivity of 95.6%-100% CT-scan without oral or rectal contrast is imaging modality of choice5,6. CT examination demonstrates number of packets, their exact location and associated complications which is usually not possible with conventional radiographs7. Saba Sohail8 concluded that body packing drugs and their location can be easily diagnosed on CT scan as they appear hyperdense (89-340 Hounsfield Unit) foreign bodies on non-contrast CT scan.

In the current study underlying hyperdense foreign entities in the stomach were seen on unenhanced CT scans of the abdomen (Figure 1), with an attenuation of around 250 Hounsfield units. A comparable hyperdense capsule was found in the transverse colon on a coronal CT picture with contrast (Figure 2), and a lower density capsule (110 HU) indicative of disintegration—a sign of systemic drug leakage—was found on a proximal duodenal CT scan (Figure 3).

Density of drugs (Hounsfield unit HU values) on CT scan also depend on the type of drug use7 such as: 

 

 

Urine analysis for toxicology is performed to aid in radiological

diagnosis and confirm about type drug causing toxicity.

Management depends upon location, size of packaging, type of

drug, symptoms of patient and complications (3).

 

CONCLUSION

Over the years body packing is increasing worldwide. This case report highlights the importance of recognizing body packing as a potential cause of abdominal pain and other gastrointestinal symptoms in patients with a history of drug use or recent travel. Radiological imaging especially CT-scan is valuable tool in diagnosing these patients and associated complications. Very limited data is available in literature about these cases and their imaging patterns especially from our country Pakistan.

 

Conflict of Interest: The authors declare no conflict of interest related to this publication.

Source of Funding: Nil.

Authors' Contributions: Kumar A: Conducted the initial clinical assessment. Ishaqi MSQ: Supervised the radiological workup. Hyder SM: Analyzed the CT findings. Aneeta: Performed the literature review and provided radiological insights. Pooja: Contributed to the discussion on gastroenterological management.

 

REFERENCES

 

  1. Gomes MJ, João A, Bargiela I. Body-packing: a rare diagnosis to keep in mind. Eur J Case Rep Intern Med. 2020;7(9):001750.

 

  1. Berger FH, Nieboer KH, Goh GS, Pinto A, Scaglione M. Body packing: a review of general background, clinical and imaging aspects. Radiol Med. 2015;120(1):118-32.

 

  1. Mandava N, Chang RS, Wang JH, Bertocchi M, Yrad J, Allamaneni S, et al. Establishment of a definitive protocol for the diagnosis and management of body packers (drug mules). Emerg Med J. 2011;28(2):98-101.

 

  1. Reginelli A, Russo A, Urraro F, Maresca D, Martiniello C, D'Andrea A, et al. Imaging of body packing: errors and medico-legal issues. Abdom Imaging. 2015;40(7):2127-42.

 

  1. Pinto A, Reginelli A, Pinto F, Sica G, Scaglione M, Berger FH, et al. Radiological and practical aspects of body packing. Br J Radiol. 2014;87(1036):20130500.

 

  1. Flach PM, Ross SG, Ampanozi G, Ebert L, Germerott T, Hatch GM, et al. "Drug mules" as a radiological challenge: sensitivity and specificity in identifying internal cocaine in body packers, body pushers and body stuffers by computed tomography, plain radiography and Lodox. Eur J Radiol. 2012;81(10):2518-26.

 

  1. Shahnazi M, Sanei Taheri M, Pourghorban R. Body packing and its radiologic manifestations: a review article. Iran J Radiol. 2011;8(4):205-10.

 

  1. Sohail S. CT scan of body packers: findings and costs. J Pak Med Assoc. 2007;57(8):400-3.

 

How to cite: Kumar A, Ishaqi MSQ, Hyder SMS, Aneeta, Pooja. Body Packing of Illicit Drugs: An Incidental Radiological Diagnosis in A COVID-Positive Patient. Pak J Med Dent Sci. 2024;1(1): 29-31